Many viruses that assemble their capsids in the eukaryotic cytoplasm require a threshold concentration of capsid protein to achieve capsid assembly. Strategies for achieving this include maintaining high levels of capsid protein synthesis and targeting to specific sites to raise the effective concentration of capsid polypeptides. To understand how different viruses achieve the threshold capsid protein concentration required for assembly, we used cell-free systems to compare capsid assembly of hepatitis B virus (HBV) and three primate lentiviruses. Capsid formation of these diverse viruses in a common eukaryotic extract was dependent on capsid protein concentration. HBV capsid assembly was also dependent on the presence of intact membrane surfaces. Surprisingly, not all of the primate lentiviral capsid proteins examined required myristoylation and intact membranes for assembly, even though all contain a myristoylation signal. These findings reveal significant diversity in how different capsid proteins assemble in the same cellular extract.
Introduction
Many different enveloped viruses, including those in the Hepadnaviridae, Retroviridae, and Flaviviridae families, assemble spherical capsids (the protein shells that house the viral genome) in the cytoplasm, or at the cytoplasmic face of a membrane. While these viruses have very different mechanisms of replication, they all face similar problems during the assembly process, which involves multimerization of capsid proteins in the crowded eukaryotic cytoplasm. Because the cytoplasm is an unfavorable environment for homotypic interactions (reviewed in Ellis, 2001) , viruses are likely to have developed mechanisms for promoting assembly of newly synthesized capsid proteins (reviewed in Garnier et al., 1998) . A comparative study of how different capsid proteins assemble in the same cellular environment would be useful for identifying whether viruses use different strategies for assembly in eukaryotic cells.
Cell-free systems that support viral capsid assembly are ideal for studying mechanisms of virus assembly in a cellular environment. These systems utilize a cellular extract to assemble capsids from newly synthesized capsid proteins, and thereby recapitulate the process of assembly that occurs in vivo. Furthermore, they are more amenable to experimental manipulation than intact cells (reviewed in Lingappa and Lingappa, in press ). Previously, we have established cell-free capsid assembly systems for studying a hepadnavirus, hepatitis B virus (HBV; Lingappa et al., 1994) , and a flavivirus, hepatitis C virus (HCV; Klein et al., 2004 , submitted for publication). In addition, we have developed cell-free assembly systems for three related primate lentiviruses: human immunodeficiency virus type 1 isolate SF2 (HIV-1 SF2; Lingappa et al., 1997; Zimmerman et al., 2002) , human immunodeficiency virus type 2 molecular clone 304 (HIV-2 304; Lingappa, 2004a, 2004b; Dooher et al., 2004) , and the Sabeus strain of simian immunodeficiency virus from African green monkeys (SIVagm Sab; Lingappa, 2004a, 2004b) . Cellfree capsid assembly systems have also been developed for Gag from the HIV-1 isolate HXB2 (Spearman and Ratner, 1996) , and Mason-Pfizer monkey virus (M-PMV), a D-type retrovirus (Sakalian and Hunter, 1999; Sakalian et al., 1996) .
During HBV assembly, the newly-synthesized structural protein core undergoes dimerization (Seifer et al., 1993; Zhou et al., 1992) followed by multimerization to form a single capsid composed of either 180 or 240 capsid proteins. HBV capsid assembly occurs in the cytoplasm and results in encapsidation of the HBV genome and polymerase as well as the cellular chaperone Hsp90 (Hu and Seeger, 1996; Hu et al., 1997) . HBV capsid formation is followed by reverse transcription of the RNA genome within the capsid, budding of the capsids into the endoplasmic reticulum (ER), and release via the secretory pathway (reviewed in Ganem and Prince, 2004; Nassal, 1999) . In contrast, a single primate lentivirus capsid is composed of~5000 copies of the viral structural protein Gag (Briggs et al., 2004) . Gag polypeptides undergo myristoylation, target to the cytoplasmic face of the plasma membrane or the multivesicular body, and multimerize at the membrane to form a single immature capsid. During assembly, the HIV genome, other viral proteins, and specific cellular proteins are packaged into the assembling capsid. Release occurs by budding from the plasma membrane, with subsequent maturation of the viral capsid occurring through the action of the viral protease (reviewed in Adamson and Jones, 2004; Freed, 1998) . The Gag proteins of HIV-1, HIV-2, and SIVagm Sab belong to different primate lentivirus subgroups (Hahn et al., 2000) , share~50% amino acid identity, and are thought to assemble in a similar manner (Dooher and Lingappa, 2004b) . Assembly of the capsid proteins of HBV (core protein) and primate lentiviruses (Gag protein) can occur in cells in the absence of other viral proteins (reviewed in Adamson and Jones, 2004; Freed, 1998; Nassal, 1996) and can be faithfully recapitulated in cell-free systems Lingappa, 2004a, 2004b; Lingappa et al., 1994 Lingappa et al., , 1997 .
A common problem faced by many viruses during assembly involves achieving the threshold level of capsid protein that is needed for their multimerization. Multiple mechanisms may exist for achieving these levels in the eukaryotic cytoplasm, and some viruses may use more than one mechanism to ensure that a sufficient concentration is reached. One mechanism for meeting the threshold concentration involves synthesis of high levels of capsid protein in the cytoplasm. For HBV, the dependence of assembly on capsid protein concentration has been demonstrated both in vitro (Ceres and Zlotnick, 2002) and in the eukaryotic cytoplasm (Seifer et al., 1993) . A second general mechanism involves targeting to raise the concentration of capsid protein at the site of assembly. Targeting to membranes is critical for directing capsid assembly to the site of release, but, in addition, membrane targeting is thought to raise local concentrations of capsid proteins, further increasing capsid protein concentration (Ono and Freed, 2001) . Such membrane targeting can be mediated by specific signals. In the case of primate lentiviral Gag proteins, targeting to membrane surfaces is governed by a N-terminal myristate (Bryant and Ratner, 1990; Gheysen et al., 1989; Gottlinger et al., 1989; Lee and Linial, 1994; Morikawa et al., 1996; Pal et al., 1990; Perez-Caballero et al., 2004) as well as adjacent basic residues (Freed et al., 1994; Ono and Freed, 1999; Ono et al., 1997; Spearman et al., 1994; Yuan et al., 1993; Zhou et al., 1994) . Nonspecific interactions of capsid proteins with RNA constitute a third mechanism for promoting multimerization. While it is thought that RNAs are used during assembly as a scaffold (Cimarelli et al., 2000; reviewed in Berkowitz et al., 1996) , they may also act to raise the local concentration of capsid proteins during assembly (reviewed in Adamson and Jones, 2004) . The effect of RNA has been described using purified recombinant retrovirus capsid protein systems in which addition of nonspecific RNA or oligonucleotides is found to promote multimerization (e.g., Campbell and Rein, 1999; Campbell and Vogt, 1995) .
Here, we compare strategies used by different viruses for concentrating capsid proteins during assembly in a cytoplasmic environment. To do this, we took advantage of cellfree assembly systems because they provide a uniform cellular context that can be manipulated experimentally. We compared the extent to which cell-free assembly of different viral capsids (HBV; HIV-1 SF2; HIV-2 304; and SIVagm Sab) is dependent upon levels of capsid protein synthesis, the presence of intact membrane surfaces, and myristoylation. Our findings reveal that different capsid proteins, including those with related sequences, use unexpectedly diverse mechanisms for assembly within the same cytoplasmic extract.
Results

Cell-free systems produce similar amounts of different viral capsid proteins
As a first step in testing the hypothesis that concentration of capsid protein is a critical determinant of assembly, we quantified the amount of capsid protein synthesized in cellfree capsid assembly systems that contain wheat germ extracts as a source of cellular factors. We have shown previously that the amount of HCV core protein produced in cell-free HCV assembly reactions is~30 ng per Al (Klein et al., 2004) , which is equivalent to~1.5 AM core protein. However, since the amount of capsid protein translated in the cell-free system may not be the same for capsid proteins of other viruses, we examined capsid protein production in two other cell-free capsid assembly systems (Fig. 1) .
Standard curves were generated by immunoblotting-specific quantities of purified, recombinant HBV core and HIV-1 SF2 Gag protein. Aliquots of unlabeled cell-free assembly reactions programmed with transcript for the 21-kDa HBV core protein or the 55-kDa HIV-1 SF2 Gag protein were immunoblotted in parallel with standards. The amount of capsid protein in each cell-free sample was determined by interpolating different quantities of cell-free assembly reactions on the appropriate standard curve. In three separate determinations, the average amount of HBV core produced was~10 ng per Al of cell-free assembly reaction (Fig. 1A) , which is equivalent to~0.5 AM. Cell-free reactions programmed with HIV-1 SF2 Gag transcript produced on average~30 ng Gag per Al of cell-free assembly reaction (Fig. 1B) , which is also~0.5 AM. Thus, comparable amounts of capsid protein (10-30 ng, or 0.5-1.5 AM) are produced when cell-free assembly systems containing wheat germ extracts are programmed with transcript encoding capsid proteins of HBV, HIV-1 SF2, or HCV.
Cell-free assembly of HBV, HIV-1 SF2 and HIV-2 304 capsids is dependent on capsid protein concentration
In cell-free assembly reactions, the amount of capsid protein produced is dependent on the amount of mRNA transcript added to the translation reaction. Previously, we have used reactions programmed with diluted transcript as a means of accumulating unassembled HBV core polypeptides (Lingappa et al., 1994) . These experiments suggested that HBV capsid assembly is sensitive to core protein concentration in the cell-free system, just as it is in cells (Seifer et al., 1993) , although the details of the cell-free concentration dependence were not examined.
To date, it remains unclear whether assembly of primate lentivirus capsids is similarly dependent on capsid protein concentration. To examine the effect of decreasing capsid protein synthesis on assembly of HBV, HIV-1 SF2, and HIV-2 304 capsids, we programmed cell-free reactions with either the standard amount of capsid transcript (100%) or with diluted transcript (Fig. 2) . Dilution of transcript was performed by mixing transcript encoding capsid protein with either mock transcript (which is programmed with water rather than a cDNA) or with transcript encoding a cellular protein (human HP68 or globin). The total amount of radiolabeled core protein translated in each reaction was determined by SDS-PAGE followed by autoradiography and densitometry. To assess amount of capsid assembly, cell-free assembly reactions were analyzed by velocity sedimentation gradients that separate completely assembled capsids from unassembled capsid protein and assembly intermediates, as previously described (Lingappa et al., 1994 (Lingappa et al., , 1997 . In the case of HBV, nearly 40% of HBV core protein assembled into~100S capsids under optimal conditions (designated maximal assembly). Dilution of HBV core transcript using mock transcript resulted in a decrease in HBV core protein synthesis as expected ( Fig.  2A , dotted line), as well as a corresponding decrease in HBV core assembly ( Fig. 2A , bar graph). Similar results were obtained when cell-free reactions were programmed with diluted HIV-1 SF2 Gag transcript (Fig. 2B ) or HIV-2 304 Gag transcript (Fig. 2C) . For example, a reduction in (25, 50, 75 , and 100 ng) was immunoblotted with anti-HBV core antibody to obtain a standard curve, shown as an immunoblot (HBV core standard). Different amounts (2.5, 5, and 10 Al) of an HBV core cell-free assembly reaction programmed with unlabeled amino acids (CFS HBV core) were analyzed in parallel with HBV core standards. Band density of HBV core standards was quantified and graphed (solid line). Band density of HBV core in cell-free reactions was also quantified and interpolated on the standard curve (best-fit line) to calculate the amount of HBV core present in 1 Al of cell-free reaction. Dotted line and solid circle show interpolation of 5 Al HBV core cell-free reaction. Average amount of HBV core present in a cell-free translation (10 ng HBV core per Al cell-free reaction) was obtained by averaging the results obtained by interpolating the 2.5, 5, and 10 Al cell-free reactions. (B) A best-fit line was obtained as described above except that different quantities of purified HIV-1 Gag standard and different amounts of an HIV-1 Gag cell-free reaction (CFS HIV-1 Gag) were used in the immunoblot. A cell-free reaction programmed with mock transcript (CFS mock) was included as a negative control. Interpolation is shown for 2.5 Al HIV-1 Gag SF2 cell-free reaction.
HIV-1 SF2 Gag synthesis to~51% of maximal synthesis resulted in a corresponding decrease in HIV-1 SF2 Gag assembly to 62% of maximal assembly (Fig. 2B ).
Primate lentiviruses differ in sensitivity of capsid assembly to membrane disruption
The wheat germ extract used in our assembly systems is a source of cellular factors for translation and assembly and also contains some small membranous organelles, such as vesicles. Sufficient concentrations of non-ionic detergents, such as Nikkol, can disrupt such membranes without affecting enzymatic reactions (Walter and Blobel, 1980) . Previously, we found that HCV capsid assembly in a cellfree system was not affected when Nikkol was added at the start of the cell-free reaction at concentrations (0.1% and 0.2%) that would be expected to disrupt membrane integrity but have no effect on protein synthesis (Klein et al., 2004) . These data suggested that HCV capsids can assemble into capsids in the absence of intact membrane surfaces. In contrast, previous data suggested that intact membrane surfaces are critical for assembly of HIV-1 SF2 Gag, since treatment of HIV assembly reactions with Nikkol at 0.1% or higher at the start of the cell-free reaction abolished HIV-1 SF2 capsid assembly (Lingappa et al., 1997 ; and see Fig. 3 ). Furthermore, when Nikkol was added at the end of the assembly reaction, no effect on HIV-1 SF2 capsids was seen, indicating that the assembly process rather than the integrity of completely assembled immature capsids is detergent sensitive (Lingappa et al., 1997) .
The striking difference in detergent sensitivity of cell-free HCV and HIV-1 SF2 capsid assembly led us to examine whether cell-free assembly of other viral capsids is dependent on intact membranes. Nikkol treatment had no significant effect on the amount of translation of any capsid protein examined (Fig. 3, autoradiographs) , and Nikkol at 0.0001%, had no effect on assembly of any capsid examined (Fig. 3) . Nikkol added at a concentration of 0.1% or greater abolished cell-free assembly of HBV capsids, as was the case for HIV-1 SF2. In contrast, 0.1% and even 0.2% Nikkol Fig. 3 . Primate lentiviruses differ in their requirement for an intact membrane surface during cell-free assembly. Cell-free assembly reactions were programmed with standard amounts of HBV, HIV-1 SF2, or HIV-2 304 transcript. At the start of the cell-free reaction, the non-ionic detergent Nikkol was added to the following final concentrations: 0.0001% Nikkol (dark grey); 0.1% Nikkol (medium grey); 0.2% Nikkol (light grey). Total volume for all cell-free reactions was kept constant. Shown below graph are autoradiographs of equivalent aliquots of total cell-free reactions. The experiments were performed three independent times for each viral capsid protein and data shown are from one representative experiment. did not affect assembly of HIV-2 304 capsids (Fig. 3, bar  graph) . The finding that HIV-2 304 immature capsid assembly was unaffected by concentrations of Nikkol that abolished HIV-1 SF2 capsid assembly in an identical extract suggests that HIV-2 304 immature capsid assembly in the cell-free system does not require intact membranes. Furthermore, these data suggest that related primate lentiviruses vary in the extent to which they require an intact membrane surface for capsid assembly. Of note, these two primate lentiviral Gag proteins share approximately 60% amino acid similarity and 50% identity (Dooher and Lingappa, 2004b) .
HIV-2 304 capsid assembly does not require myristoylation of Gag, in contrast to other primate lentiviruses All lentiviral Gag proteins examined here contain an Nterminal myristoylation signal (Fig. 4A) , while HBV core does not. Myristoylation occurs at the consensus sequence, Met-Gly-X-X-X-Ser/Thr, and is catalyzed by the enzyme Nmyristoyl transferase , using myristoyl coenzyme A (MCoA) as a fatty acid donor. Wheat germ extract contains N-myristoyl transferase (Heuckeroth et al., 1988) , however, during processing of wheat germ, small molecules such as MCoA are lost during gel filtration. For this reason, MCoA must be added exogenously to cell-free capsid assembly systems for sufficient myristoylation to occur. Several lines of evidence indicate that myristoylation of HIV-1 Gag is important for HIV-1 Gag multimerization in cells, in addition to Gag targeting and release. For example, full-length Gag proteins containing a GDA mutation (2GDA) that abolishes myristoylation (Bryant and Ratner, 1990; Gottlinger et al., 1989) fail to produce capsid-like structures in primate cells, as indicated by electron microscopic analyses (Spearman et al., 1994) . Consistent with this observation, we previously found that myristoylation of HIV-1 SF2 Gag is required for efficient assembly of immature HIV-1 SF2 capsids in the cell-free system (Lingappa et al., 1997) .
For this reason and because of the differences observed in membrane dependence, we examined whether myristoylation is critical for assembly of SIVagm Sab and HIV-2 304 immature capsids, as is the case for HIV-1 SF2 capsid assembly. HIV-1 SF2 Gag did not assemble to a significant extent in the absence of MCoA (Fig. 4B graph, lanes 1 and 2), as previously reported (Lingappa et al., 1997) . Similarly, SIVagm Sab Gag did not assemble efficiently into~750S Fig. 4 . Some but not all primate lentiviruses require Gag myristoylation for immature capsid assembly in the cell-free system. (A) Alignment of N-terminal amino acids for the three primate lentiviral Gag proteins studied here shows that all contain the myristoylation consensus: Met-Gly-X-X-X-Ser/Thr, followed by a region high in basic charge. White shading indicates identity; grey indicates conservative substitution; black shading indicates non-conservative substitution. (B) Cell-free reactions were programmed with the indicated transcripts either in the presence (+) or absence (À) of myristoyl CoA (MCoA). Reactions were analyzed by velocity sedimentation and the amount of assembly into completed capsids was determined and quantitated (as % of total capsid protein). Shown below the graph are autoradiographs of equivalent aliquots of each translation reaction performed in the presence and absence of MCoA. All lanes are from the same film except for SIVagm Sab, which is synthesized at lower levels and requires a longer exposure, and HBV, which was analyzed in a separate experiment containing an HIV-1 control. The experiment was performed three independent times for each viral capsid protein and representative data are shown here. completed immature capsids in the absence of exogenously added MCoA (Fig. 4B graph, lanes 5 and 6) . Surprisingly, HIV-2 304 Gag assembled into~750S immature capsids to a similar extent in the presence or absence of MCoA (Fig. 4B  graph, lanes 7 and 8) . To confirm these results, we engineered a 2GDA mutation in HIV-2 304 Gag to abolish its myristoylation consensus. An analogous mutation in HIV-1 SF2 Gag has been shown to abolish cell-free capsid assembly (Lingappa et al., 1997; and Fig. 4B graph, lanes 3  and 4) . In contrast to results obtained with HIV-1 SF2 GDA Gag, cell-free reactions programmed with HIV-2 304 GDA Gag assembled efficiently in the presence or absence of MCoA (Fig. 4B graph, lanes 9 and 10, compare to lanes 3  and 4) . These data suggest that, like HIV-1, SIVagm Sab Gag requires myristoylation for assembly, while HIV-2 304 Gag does not. As expected, assembly of HBV core, which does not contain a myristoylation signal, was unaffected by addition of MCoA (Fig. 4B graph, lanes 11 and 12) . Amount of synthesis of all constructs was not altered by addition of MCoA (Fig. 4B, autoradiograph) , as expected.
To validate that the~750S complexes made by HIV-2 304 Gag in the absence of MCoA are indeed immature capsids, we harvested these particles following velocity sedimentation and subjected them to equilibrium centrifugation on cesium chloride, which separates particles by density (in contrast to velocity sedimentation, which separates particles on the basis of size and shape). Both the~750S complexes produced by HIV-1 SF2 Gag in the presence of MCoA and the~750S complexes produced by HIV-2 304 Gag in the absence of MCoA migrated in the same fractions on cesium gradients, peaking in fraction 5 (Fig. 5) . Refractometry measurements revealed that fraction 4 corresponds to a density of 1.36 g/ml, which is the expected density of immature primate lentivirus capsids in cesium chloride (Dooher et al., 2004; Lingappa et al., 1997) . Together, these data indicate that HIV-2 304 Gag, unlike HIV-1 SF2 and SIVagm Sab Gag, efficiently assembles into immature capsids of the correct size, shape, and density in the cell-free system even in the absence of myristoylation. Thus, cell-free capsid assembly of these three related primate lentiviruses differs in dependence on myristoylation, even though all three contain myristoylation signals in the N-termini that fit the canonical consensus and closely resemble each other (Fig. 4B) .
Discussion
In comparing assembly of different viral capsid proteins in a cellular extract, we have identified surprising differences in how different capsid proteins achieve threshold capsid protein concentrations needed for assembly. Use of cell-free systems allowed us to alter one variable, such as concentration of capsid protein transcript, presence of intact membranes, and presence of the cofactor for myristoylation, while keeping other relevant variables constant. We found that HBV capsid assembly in the cell-free system ( Fig. 2A) recapitulates the concentration dependence seen for HBV in cells (Seifer et al., 1993) . In addition, assembly of HIV-1 SF2 and HIV-2 304 capsids display a similar dependence on capsid protein concentration (Figs. 2B and C) , suggesting that diverse viruses require threshold levels of capsid protein synthesis. However, not all viral capsids appear to share this characteristic. We recently demonstrated that HCV capsid assembly in a cell-free system is relatively concentration independent (Klein et al., 2004) , despite capsid protein levels comparable to those found in the concentration dependent systems described here (see Fig. 1 ). These Fig. 5 . Non-myristoylated HIV-2 304 Gag forms capsids as indicated by buoyant density measurements. Cell-free reactions programmed with HIV-1 SF2 Gag in the presence of MCoA and HIV-2 304 Gag in the absence of MCoA were subjected to velocity sedimentation. Fractions containing~750S complexes were layered onto cesium chloride and subjected to equilibrium centrifugation. Half of each fraction was subjected to refractometry to obtain density of each fraction in g/ml (dotted line with shaded triangles). The other half of each fraction was analyzed by SDS-PAGE and autoradiography. Solid lines show the amount of radiolabeled HIV-1 SF2 Gag (dark squares) and HIV-2 304 Gag (open diamonds) in each cesium fraction plotted against the fraction number, and in both cases reveals a peak at 1.36 g/ml. The experiment was repeated twice and the results shown are from one representative experiment.
extreme differences in the concentration dependence of capsid assembly of different viruses within the same extract raise the possibility that two fundamentally different assembly mechanisms exist for viral capsids that assemble at cytoplasmic faces of membranes. Examination in cellular systems will be required to test this hypothesis.
While the three primate lentiviruses we studied showed a similar dependence on the level of capsid protein synthesis, they differed in their dependence on myristoylation and intact membranes for the purpose of promoting capsid assembly. Cell-free assembly of HIV-1 SF2 Gag was dependent on intact membranes and myristoylation, while cell-free assembly of HIV-2 304 Gag did not display a membrane dependence or require myristoylation (Figs. 3  and 4) . In intact cells, proper assembly of wild-type HIV-1 Gag appears to require myristoylation (Spearman et al., 1994) , although the exact reason for this remains unclear. Current thinking holds that Gag-Gag interactions that occur during multimerization cause a conformational change that exposes the myristate at the N-terminus of Gag and leads to membrane binding (the myristoyl switch model; e.g. Ono et al., 2000; Paillart and Gottlinger, 1999; Perez-Caballero et al., 2004; Sandefur et al., 2000; Spearman et al., 1994; Zhou et al., 1994) . Membrane binding is thought to raise the local concentration of Gag at the membrane to the threshold needed for subsequent multimerization of Gag, resulting in capsid assembly at the appropriate site for release. Therefore, we were surprised to find that HIV-2 304 Gag can assemble efficiently in the absence of myristoylation or intact membranes in the cell-free system. These data suggest that some primate lentiviral Gag polyprotein variants may contain sequence differences that allow them to utilize other mechanisms for promoting assembly, while still using myristoylation and membrane targeting in cells to ensure virus release by budding from the plasma membrane. An alternate assembly scheme is seen with the D-type retrovirus Mason-Pfizer monkey virus (M-PMV), which appears to use an 18-amino acid cytoplasmic targeting/retention signal (CTRS) to concentrate its Gag proteins in the pericentriolar region where assembly occurs (Choi et al., 1999; Rhee and Hunter, 1987; Sfakianos et al., 2003) . The hypothesis that alternate concentrating mechanisms may exist for some primate lentiviral Gag proteins will need to be tested by examining whether HIV-2 304 assembly can occur independently of myristoylation and membrane targeting in intact cells.
In our study, assembly of HBV capsids was not dependent on myristoylation, as expected given the lack of a myristoylation signal in HBV core. Interestingly, assembly of HBV capsids was detergent sensitive, implying that an intact membrane surface is required for assembly in the cellfree system. HBV core is known to contain a nuclear localization signal and a nuclear export signal (Kann et al., 1999; Mabit et al., 2001; Rabe et al., 2003) , but is not known to contain intrinsic membrane targeting signals. An alternate form of core (precore) that gives rise to the HBV e antigen is known to contain a signal sequence that targets it to the ER (Garcia et al., 1988) , but precore is not thought to give rise to capsid protein in vivo and was not utilized in this study. HBV capsids are thought to assemble in the cytoplasm and subsequently target to the ER by associating with hepatitis B surface antigen expressed in the ER (reviewed in Ganem and Prince, 2004; Nassal, 1996) , but our data raise the possibility that core may also have an intrinsic membrane targeting signal that acts before or during capsid assembly.
In conclusion, our studies of the behavior of diverse capsid proteins during assembly in a common cellular extract reveal significant differences in features of capsid protein assembly. HBV and some primate lentiviral capsid proteins (HIV-1 SF2 and SIVagm Sab) require threshold levels of capsid protein synthesis as well as membrane targeting to assemble efficiently in the cell-free system, while another primate lentivirus (HIV-2 304) requires threshold levels of capsid protein synthesis but does not require membrane targeting for efficient capsid assembly. This finding contrasts with previous studies showing that HCV requires neither high levels of synthesis nor intact membranes for assembly in the cell-free system (Klein et al., 2004) . Together, these observations suggest that viral capsids that assemble at cytoplasmic membrane faces rely to different extents on a variety of mechanisms for achieving threshold concentrations of their capsid proteins.
Materials and methods
Plasmids
Plasmids for cell-free expression were derived from SP64 vector (Promega) into which the 5V untranslated region (UTR) of Xenopus laevis globin had been inserted at the HindIII site (Melton et al., 1984) . Coding regions for HBV core (Lingappa et al., 1994) , HIV-1 SF2 Gag (Lingappa et al., 1997) , HIV-2 304 Gag (Dooher and Lingappa, 2004b) , SIVagm Sab Gag (Dooher and Lingappa, 2004a) , Flagtagged HuHP68 (Dooher and Lingappa, 2004b) , and globin (Zimmerman et al., 2002) were inserted into this vector downstream from the UTR as described previously. Note that the Gag constructs used encode full-length Gag (e.g., HIV-1 p55 Gag) but do not encode the viral protease and therefore only produce immature capsids.
Cell-free reactions
In vitro transcription was performed with SP6 polymerase using cell-free expression plasmids described above. Cell-free translation and assembly reactions were performed by incubating transcript (20%) with wheat germ extract (20%), 19 unlabeled amino acids, 35 S-methionine (Translabel, ICN), ATP, GTP, creatine phosphate, creatine kinase and RNAse A inhibitor for 180 min at 26 8C as described previously (Erickson and Blobel, 1983; Lingappa et al., 1997) . Cell-free reactions in Fig. 1 were performed with 20 unlabeled amino acids and without radiolabel. Fig. 1 included HBV core (a gift of Chiron corporation), and purified recombinant HIV-1 SF2 p55 Gag (catalog 5109) from the NIH AIDS Reference and Reagent Program (donated by Chiron corporation). Immunoblotting was performed using a-HBV core antibody (Dako) at 1:1000, or a-HIV-1 Gag p24 (Dako) at 1:600, respectively. Anti-IgG coupled to horseradish peroxidase (HRP; Santa Cruz) was used as a secondary antibody and enhanced chemiluminescence (Pierce) was performed. Unlabeled cellfree reactions were analyzed on the same immunoblot as standards, and immunoblots were quantitated within the linear range of detection (see below).
Immunoblotting
Standards in
Gradient analysis
Ten Al of each cell-free reaction was diluted into 100 Al NP40 buffer (10 mM TrisAc pH 7.4, 0.625% NP40, 50 mM KAc, 100 mM NaCl, and 4 mM Mg) and analyzed by velocity sedimentation to separate completed capsids from assembly intermediates. The following 2 ml gradients containing sucrose in NP40 buffer were centrifuged using a TLS55 rotor in a Beckman Optima Max E at 4 8C. To separate the~100S HBV completed capsid, samples were layered onto 10-50% sucrose gradient and centrifuged at 55,000 rpm (200,000 Â g) for 55 min. For separation of thẽ 750S completed capsid of HIV-1, HIV-2, and SIVagm Sab, samples were layered onto step gradients containing 500 Al each of 20%, 40%, 50%, and 75% sucrose (Figs. 2B, 3 , and 4) or 400 Al each of 20%, 40%, 50%, 66%, and 75% sucrose (Fig. 2C ), and were centrifuged at 45,000 rpm (135,000 Â g) for 45 min. Position of completed capsids was determined by migration of authentic immature capsids produced in cells (data not shown and methods described previously (Lingappa et al., 1994 (Lingappa et al., , 1997 ). Calibration of gradients to determine S value positions has been described previously (Lingappa et al., 1997) . Two hundred Al fractions were collected from the top and a 10 Al aliquot of each was analyzed by SDS-PAGE and autoradiography. Percent assembly was defined as the amount of capsid protein in the assembled position in the gradient as a % of total capsid protein synthesized.
Equilibrium centrifugation was performed by layering sample (50 Al each of velocity sedimentation gradient fractions containing~750S completed capsids of HIV-1 or HIV-2 304) onto cesium chloride (337 mg/ml) and centrifuging at 50,000 rpm (166,000 Â g) for 22 h at 25 8C in a TLS55 rotor. Two hundred Al fractions were collected and half of each fraction was precipitated with trichloroacetic acid, washed with ethanol-ether, and analyzed by SDS-PAGE and autoradiography. The remainder of each fraction was used to obtain refractive index measurements of each fraction, which were converted to density measurements using a standard conversion table.
Quantitation
Autoradiographs and immunoblots were digitized using an AGFA Duoscan T1200 scanner and Adobe Photoshop 6.0 software (Adobe Systems Incorporated). Mean band densities were determined and adjusted for band size and background using Image J software (NIH).
